UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Methodological Considerations in the Evaluation of Radiotherapy Technologies

Clinical oncology (Royal College of Radiologists (Great Britain)), 2012-12, Vol.24 (10), p.707-709

2012

Volltextzugriff (PDF)

The National Lung Matrix Trial: translating the biology of stratification in advanced non-small-cell lung cancer

Annals of oncology, 2015-12, Vol.26 (12), p.2464-2469

2015

Volltextzugriff (PDF)

Radiotherapy Research Priorities for the UK

Clinical oncology (Royal College of Radiologists (Great Britain)), 2010-10, Vol.22 (8), p.707-709

2010

Volltextzugriff (PDF)

Effect of topical imiquimod as primary treatment for lentigo maligna: the LIMIT‐1 study

British journal of dermatology (1951), 2017-05, Vol.176 (5), p.1148-1154

2017

Volltextzugriff (PDF)

Anatomy of a phase III clinical trial: vivisecting BTOG2

Lung cancer (Amsterdam, Netherlands), 2008, Vol.60, p.S20-S21

2008

Volltextzugriff (PDF)

Palliative Chemotherapy: No Longer a Contradiction in Terms

The oncologist (Dayton, Ohio), 1999-12, Vol.4 (6), p.470-477

1999

Volltextzugriff (PDF)

Phase I II trial of a dendritic cell vaccine transfected with DNA encoding melan A and gp100 for patients with metastatic melanoma

Gene therapy, 2011-06, Vol.18 (6), p.584-593

2011

Volltextzugriff (PDF)

5014 Estrogen and progesterone receptor as predictive biomarkers of response to endocrine therapy: a prospectively powered pathology study in the tamoxifen and exemestane adjuvant multinational (TEAM) trial

European journal of cancer supplements, 2009, Vol.7 (2), p.264-264

2009

Volltextzugriff (PDF)

The benefits of chemotherapy in patient subgroups with unresectable non-small-cell lung cancer

Annals of oncology, 2001-12, Vol.12 (12), p.1671-1675

2001

Volltextzugriff (PDF)

239 The unattainability of bladder cancer biomarkers: Utility-based assessment of a hypothetical non-invasive surveillance tool for bladder cancer recurrence

European urology supplements : official journal of the European Association of Urology, 2013-03, Vol.12 (1), p.e239-e239

2013

Volltextzugriff (PDF)

Follow up after Primary Treatment of Soft Tissue Sarcoma: A Survey of Current Practice in the United Kingdom

Sarcoma, 2007, Vol.2007, p.13-18

2007

Volltextzugriff (PDF)

Examining the benefits of chemotherapy in subgroups of patients with inoperable non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2000-09, Vol.29 (1), p.4-4

2000

Volltextzugriff (PDF)

Patterns, costs and cost-effectiveness of care in a trial of chemotherapy for advanced non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2002-08, Vol.37 (2), p.219-225

2002

Volltextzugriff (PDF)

The effect of Epstein–Barr virus status on outcome in age- andsex-defined subgroups of patients with advanced Hodgkin’s disease

Annals of oncology, 2003-02, Vol.14 (2), p.282-290

2003

Volltextzugriff (PDF)

The use of selenium and vitamin E supplementation to prevent recurrence of non-muscle-invasive bladder cancer: results of the SELENIB trial

European urology supplements : official journal of the European Association of Urology, 2019-03, Vol.18 (1), p.e764-e765

2019

Volltextzugriff (PDF)

576 - The use of selenium and vitamin E supplementation to prevent recurrence of non-muscle-invasive bladder cancer: results of the SELENIB trial

European urology supplements : official journal of the European Association of Urology, 2019-03, Vol.18 (1), p.e764-e765

2019

Volltextzugriff (PDF)

8 Mitomycin, ifosfamide and cisplatin (MIC) in non-small cell lung cancer (NSCLC): 4. Assessing the effect of chemotherapy across prognostic strata in over 800 randomised patients with inoperable disease

Lung cancer (Amsterdam, Netherlands), 1997-08, Vol.18, p.4-5

1997

Volltextzugriff (PDF)

26 Mitomycin, ifosfamide and cisplatin (MIC) in non-small cell lung cancer (NSCLC): 3. Results of a randomised trial evaluating palliation & quality of life

Lung cancer (Amsterdam, Netherlands), 1997-08, Vol.18, p.9-10

1997

Volltextzugriff (PDF)

11 Mitomycin, ifosfamide and cisplatin (MIC) in non-small cell lung cancer (NSCLC): 2. Results of a randomised trial in patients with extensive disease

Lung cancer (Amsterdam, Netherlands), 1997-08, Vol.18, p.5-5

1997

Volltextzugriff (PDF)

10 Mitomycin, ifosfamide and cisplatin (MIC) in non-small cell lung cancer (NSCLC): 1. Results of a randomised trial in patients with localised, inoperable disease

Lung cancer (Amsterdam, Netherlands), 1997-08, Vol.18, p.5-5

1997

Volltextzugriff (PDF)

1 – 20 von 20

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(17)
Mit Volltextzugriff
(20)

Publikationsform

Artikel
(20)

Sprache

Englisch
(20)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Methodological Considerations in the Evaluation of Radiotherapy Technologies

The National Lung Matrix Trial: translating the biology of stratification in advanced non-small-cell lung cancer

Radiotherapy Research Priorities for the UK

Effect of topical imiquimod as primary treatment for lentigo maligna: the LIMIT‐1 study

Anatomy of a phase III clinical trial: vivisecting BTOG2

Palliative Chemotherapy: No Longer a Contradiction in Terms

Phase I II trial of a dendritic cell vaccine transfected with DNA encoding melan A and gp100 for patients with metastatic melanoma

5014 Estrogen and progesterone receptor as predictive biomarkers of response to endocrine therapy: a prospectively powered pathology study in the tamoxifen and exemestane adjuvant multinational (TEAM) trial

The benefits of chemotherapy in patient subgroups with unresectable non-small-cell lung cancer

239 The unattainability of bladder cancer biomarkers: Utility-based assessment of a hypothetical non-invasive surveillance tool for bladder cancer recurrence

Follow up after Primary Treatment of Soft Tissue Sarcoma: A Survey of Current Practice in the United Kingdom

Examining the benefits of chemotherapy in subgroups of patients with inoperable non-small cell lung cancer

Patterns, costs and cost-effectiveness of care in a trial of chemotherapy for advanced non-small cell lung cancer

The effect of Epstein–Barr virus status on outcome in age- andsex-defined subgroups of patients with advanced Hodgkin’s disease

The use of selenium and vitamin E supplementation to prevent recurrence of non-muscle-invasive bladder cancer: results of the SELENIB trial

576 - The use of selenium and vitamin E supplementation to prevent recurrence of non-muscle-invasive bladder cancer: results of the SELENIB trial

8 Mitomycin, ifosfamide and cisplatin (MIC) in non-small cell lung cancer (NSCLC): 4. Assessing the effect of chemotherapy across prognostic strata in over 800 randomised patients with inoperable disease

26 Mitomycin, ifosfamide and cisplatin (MIC) in non-small cell lung cancer (NSCLC): 3. Results of a randomised trial evaluating palliation & quality of life

11 Mitomycin, ifosfamide and cisplatin (MIC) in non-small cell lung cancer (NSCLC): 2. Results of a randomised trial in patients with extensive disease

10 Mitomycin, ifosfamide and cisplatin (MIC) in non-small cell lung cancer (NSCLC): 1. Results of a randomised trial in patients with localised, inoperable disease

Suchergebnisse filtern